{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.666.5.2350","meta":{"versionId":"12","lastUpdated":"2016-03-31T01:00:12.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Immunocompromised Therapies I9</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://hl7.org/fhir/sid/icd-9-cm</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>00.10</td>\n              <td>Implantation of chemotherapeutic agent</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>00.15</td>\n              <td>High-dose infusion interleukin-2 [IL-2]</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>17.70</td>\n              <td>Intravenous infusion of clofarabine</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>99.25</td>\n              <td>Injection or infusion of cancer chemotherapeutic substance</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>99.28</td>\n              <td>Injection or infusion of biological response modifier [BRM] as an antineoplastic agent</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2350","version":"20160331","name":"Immunocompromised Therapies I9","status":"active","date":"2016-03-31T01:00:12-04:00","publisher":"Lantana EH Steward","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-9-cm","concept":[{"code":"00.10","display":"Implantation of chemotherapeutic agent"},{"code":"00.15","display":"High-dose infusion interleukin-2 [IL-2]"},{"code":"17.70","display":"Intravenous infusion of clofarabine"},{"code":"99.25","display":"Injection or infusion of cancer chemotherapeutic substance"},{"code":"99.28","display":"Injection or infusion of biological response modifier [BRM] as an antineoplastic agent"}]}]}}